Biotech

All Articles

Fierce Biotech Managing Editor Ayla Ellison Talks Shop with Michelle Benz on the Future of Biotech.

.Let's study a chat with Ayla Ellison, Intense Biotech Managing Editor and also Michelle Benz as the...

New records demonstrate how Bayer's asundexian failed to prevent strokes

.Bayer suspended the phase 3 test for its element XIa prevention asundexian behind time in 2014 afte...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS tests

.Sanofi is still set on taking its several sclerosis (MS) med tolebrutinib to the FDA, managers have...

Galapagos' stockpile as fund reveals intent to shape its evolution

.Galapagos is actually happening under extra tension from capitalists. Having actually constructed a...

Cell- centered Sana scoops first CSO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of significant management hirings, firings as we...

Allist settles Jacobio $21M, landing part in Mandarin KRAS race

.Shanghai Allist Pharmaceuticals has gotten itself a starring role in China's KRAS market, spending ...

ReNeuron leaving goal swap after missing out on fundraising goal

.ReNeuron has actually signed up with the long checklist of biotechs to leave behind London's intent...

MBX files for IPO to take challenger to Ascendis in to phase 3

.MBX Biosciences has contributed to the latest flurry of IPO filings. The biotech, which submitted i...

FDA increases probing right into Lykos' MDMA tests: WSJ

.For Lykos Rehabs and also the firm's potential MDMA-assisted therapy for post-traumatic stress diso...

Gene publisher Volume giving up 131 laborers

.Simply days after genetics editor Volume Biosciences introduced hidden operational cuts, a clearer ...